| 2.26 -0.21 (-8.5%) | 04-20 16:00 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 2.89 | 1-year : | 3.38 |
| Resists | First : | 2.48 | Second : | 2.89 |
| Pivot price | 2.17  |
|||
| Supports | First : | 2.04 | Second : | 1.77 |
| MAs | MA(5) : | 2.33 |
MA(20) : | 2.1 |
| MA(100) : | 2.06 |
MA(250) : | 2.55 |
|
| MACD | MACD : | 0.1 |
Signal : | 0 |
| %K %D | K(14,3) : | 81.3 |
D(3) : | 84.8 |
| RSI | RSI(14): 57.4 |
|||
| 52-week | High : | 6.25 | Low : | 1.5 |
Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.[ CELZ ] has closed below upper band by 35.4%. Bollinger Bands are 12.2% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 2.46 - 2.47 | 2.47 - 2.48 |
| Low: | 2.14 - 2.16 | 2.16 - 2.17 |
| Close: | 2.24 - 2.26 | 2.26 - 2.28 |
Creative Medical Technology Holdings, Inc., a biotechnology company, focuses on immunology, urology, orthopedics, and neurology using adult stem cell treatments. The company offers CaverStem to treat erectile dysfunction; FemCelz for the treatment of loss of genital sensitivity and dryness; StemSpine to treat chronic lower back pain; ImmCelz for the treatment of stroke patients; and OvaStem for treatment of female infertility. Creative Medical Technology Holdings, Inc. is based in Phoenix, Arizona.
Thu, 09 Apr 2026
Analysts Expect Breakeven For Creative Medical Technology Holdings, Inc. (NASDAQ:CELZ) Before Long - Yahoo Finance
Sun, 22 Mar 2026
If You Invested $1,000 in Creative Med Technology Hldgs (CELZ) - Stock Titan
Tue, 10 Feb 2026
Creative Medical Technology Holdings, Inc. Achieves Milestone with WHO for Second INN Recognition of CELZ-101 - Quiver Quantitative
Tue, 10 Feb 2026
Two Creative Medical cell therapies gain WHO naming milestones - Stock Titan
Tue, 06 Jan 2026
Creative Medical’s BioDefense initiative receives regulatory approval - Investing.com
Wed, 05 Nov 2025
Creative Medical Technology Holdings, Inc. (CELZ) - Zacks Investment Research
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Outperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Biotechnology
|
|
| Shares Out | 0 (M) |
| Shares Float | 4 (M) |
| Held by Insiders | 3.43e+006 (%) |
| Held by Institutions | 0.9 (%) |
| Shares Short | 320 (K) |
| Shares Short P.Month | 0 (K) |
| EPS | -6.02e+006 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0 |
| Profit Margin | 0 % |
| Operating Margin | -64 % |
| Return on Assets (ttm) | 859.4 % |
| Return on Equity (ttm) | -53.1 % |
| Qtrly Rev. Growth | 6000 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | -43.46 |
| EBITDA (p.s.) | 1914.57 |
| Qtrly Earnings Growth | -2.6 % |
| Operating Cash Flow | 0 (M) |
| Levered Free Cash Flow | -6 (M) |
| PE Ratio | -0.01 |
| PEG Ratio | 0 |
| Price to Book value | 0 |
| Price to Sales | -0.06 |
| Price to Cash Flow | 2.21 |
| Dividend | 0 |
| Forward Dividend | 343040 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|